Media & Research Roundup - April 2025
By Bill and Terri Weitze
CONTENT WARNING: Some articles featured in the Media & Research Roundup may refer to stigmatizing events or use stigmatizing language. Websites hosting the articles linked below may allow advertisements for weight loss products and/or otherwise problematic ads.
March 4, 2025: Mice who have a certain form of brown fat have an expanded lifespan and increased exercise capacity. Researchers are now working on developing a drug to mimic these effects in humans.
March 13, 2025: Australian healthcare professionals recommend better screening for patients asking for weight loss drugs to ensure that they are not being used to enable or foster eating disorders and weight stigma.
March 15, 2025: A five-year follow up on the effectiveness of digital health behavior systems shows that this type of program is no more effective at maintaining weight loss than non-digital programs.
March 16, 2025: Rebecca Shaw, writing for The Guardian, talks about how progress against fat phobia and fat hatred seems to be slipping away. Now is the time to push back because fat people aren’t going anywhere.
March 17, 2025: A doctor discusses weight-inclusive healthcare, the ineffectiveness of diets, and harms associated with weight-centric medicine.
March 19, 2025: Fat cancer patients with solid tumor malignancies who receive immune checkpoint inhibitor therapy have a significantly improved overall survival.
March 25, 2025: This article discusses how practitioners with larger body size are not taken seriously in many healthcare settings and the harm this lack of diversity can cause.
March 25, 2025: Despite a lack of evidence for adverse outcomes, higher weight women are finding it more difficult to obtain abortions.
March 29, 2025: Great profiles of higher-weight fitness instructors showing that fat and fit is not an oxymoron but look out for the obligatory “but you should lose weight” stuck in the middle of the article.
April 4, 2025: Trump dropped the Biden administration proposal to have Medicare cover obesity drugs; however, the Centers for Medicare and Medicaid Services says it may revisit coverage of those drugs in the future.